A role for STAT5 in the pathogenesis of IL-2-induced glucocorticoid resistance

scientific article published on November 2002

A role for STAT5 in the pathogenesis of IL-2-induced glucocorticoid resistance is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.4049/JIMMUNOL.169.10.5934
P698PubMed publication ID12421978
P5875ResearchGate publication ID11044291

P2093author name stringDonald Y M Leung
Elena Goleva
Kevin O Kisich
P433issue10
P407language of work or nameEnglishQ1860
P304page(s)5934-5940
P577publication date2002-11-01
P1433published inJournal of ImmunologyQ3521441
P1476titleA role for STAT5 in the pathogenesis of IL-2-induced glucocorticoid resistance
P478volume169

Reverse relations

cites work (P2860)
Q35989445ATF2 impairs glucocorticoid receptor-mediated transactivation in human CD8+ T cells.
Q39297161Activation of cAMP-protein kinase A abrogates STAT5-mediated inhibition of glucocorticoid receptor signaling by interferon-alpha
Q42684792Basiliximab for the treatment of steroid-resistant ulcerative colitis: further experience in moderate and severe disease
Q36915488Body mass and glucocorticoid response in asthma.
Q91990130CRLF2 rearrangement in Ph-like acute lymphoblastic leukemia predicts relative glucocorticoid resistance that is overcome with MEK or Akt inhibition
Q36615053Correction of anaemia through the use of darbepoetin alfa improves chemotherapeutic outcome in a murine model of Lewis lung carcinoma.
Q36637116Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression
Q36101717Cytokines and glucocorticoid receptor signaling. Relevance to major depression
Q42045890Cytokines induce an early steroid resistance in airway smooth muscle cells: novel role of interferon regulatory factor-1.
Q43141763Decoy oligodeoxynucleotide against STAT transcription factors decreases allergic inflammation in a rat asthma model
Q39157135Discovery of GW870086: a potent anti-inflammatory steroid with a unique pharmacological profile
Q27001541Endoplasmic reticulum stress and the related signaling networks in severe asthma
Q38307578Enhanced expression of adipocyte-type fatty acid binding protein in murine lymphocytes in response to dexamethasone treatment
Q40553683Enhancement of MEK/ERK signaling promotes glucocorticoid resistance in CD4+ T cells
Q24642399Glucocorticoid receptor interacting protein-1 restores glucocorticoid responsiveness in steroid-resistant airway structural cells
Q37501546Glucocorticoid resistance in inflammatory diseases.
Q91584309Glucocorticoid sensitivity: pathology, mutations and clinical implications
Q28077040Glucocorticoid-independent modulation of GR activity: Implications for immunotherapy
Q51802719Glucocorticoids and the emerging importance of T cell subsets in steroid refractory diseases.
Q34903070Glucocorticosteroids: current and future directions
Q37078027IFN-gamma reverses IL-2- and IL-4-mediated T-cell steroid resistance
Q93149194IL-2 modulates Th2 cell responses to glucocorticosteroid: A cause of persistent type 2 inflammation?
Q37144416Increased glucocorticoid receptor beta alters steroid response in glucocorticoid-insensitive asthma
Q64906046Inflammatory Signaling in Hypertension: Regulation of Adrenal Catecholamine Biosynthesis.
Q41881199Interferon-alpha inhibits glucocorticoid receptor-mediated gene transcription via STAT5 activation in mouse HT22 cells
Q36392316Kinase inhibitors and airway inflammation.
Q51322803Maternal low-protein diet induces gender-dependent changes in epigenetic regulation of the glucose-6-phosphatase gene in newborn piglet liver.
Q37341018Mechanisms regulating the susceptibility of hematopoietic malignancies to glucocorticoid-induced apoptosis
Q36670211Modelling the glucocorticoid receptor and producing therapeutic agents with anti-inflammatory effects but reduced side-effects
Q42703436Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease.
Q37710516Pharmacogenomics in the treatment of inflammatory bowel disease
Q24306562Regulation of apoptosis by the Ft1 protein, a new modulator of protein kinase B/Akt
Q36710336Review article: steroid resistance in inflammatory bowel disease - mechanisms and therapeutic strategies
Q38087650Role of transcription factors in the pathogenesis of asthma and COPD.
Q51040026Steroid resistance of airway type 2 innate lymphoid cells from patients with severe asthma: The role of thymic stromal lymphopoietin
Q26771607Stress-Related Immune Markers in Depression: Implications for Treatment
Q51051670T cells from burn-injured mice demonstrate a loss of sensitivity to glucocorticoids
Q35873472T lymphocyte insensitivity to corticosteroids in chronic obstructive pulmonary disease
Q37103363The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findings
Q37338762The links between chronic obstructive pulmonary disease and comorbid depressive symptoms: role of IL-2 and IFN-γ.
Q37573811Therapeutic targets for new therapy for corticosteroid refractory asthma
Q53085315Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation.

Search more.